PDCD4 and esophageal squamous cell carcinoma: The present study firstly indicated the key data about regulation of miR-21 over PDCD4 in Kazakh's ESCC, experimentally demonstrating that targeting against miR-21 could be a potential therapeutic strategy in the management of patients with ESCC.